Best practices for the interpretation and reporting of clinical genome sequencing
Genetics in Medicine(2022)
摘要
Genome sequencing (GS) exhibits high analytical performance and shows promise as a first-tier diagnostic test for patients with rare genetic disorders. Compared to exome sequencing (ES) and other molecular diagnostic tests (e.g. sequencing panels, microarrays), GS is more comprehensive for two reasons: (i) it allows detection of a broader range of variant types in a single assay, including single nucleotide variants (SNV), small insertions and deletions, mitochondrial variants (MT), repeat expansions (RE), copy number variants (CNV) and other structural variants (SV); and (ii) it is untargeted, resulting in more uniform coverage of exonic regions and added coverage of intronic, intergenic and regulatory regions.
更多查看译文
关键词
clinical genome,reporting
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要